# DPP-4 Inhibitor and Serum BNP Level of Diabetic Patients With Congestive Heart Failure

> **NCT02312427** · PHASE4 · COMPLETED · sponsor: **Mitsui Memorial Hospital** · enrollment: 10 (actual)

## Conditions studied

- Heart Failure
- Diabetes Mellitus

## Interventions

- **DRUG:** Suspending DPP-4 inhibitor, in outpatient service
- **DRUG:** Starting DPP-4 inhibitor after treatment of heart failure
- **DRUG:** Suspending DPP-4 inhibitor after treatment of heart failure

## Key facts

- **NCT ID:** NCT02312427
- **Lead sponsor:** Mitsui Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-03-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02312427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02312427, "DPP-4 Inhibitor and Serum BNP Level of Diabetic Patients With Congestive Heart Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02312427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*